WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2026 Issue has been successfully launched on1 OCTOBER 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR October 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

  Indexing

  • Google Scholar
  • Index Copernicus
  • SOCOLAR, China
  • Research Bible, Fuchu, Tokyo. JAPAN
  • Cosmos Impact Factor
  • Scientific Indexing Services (SIS)
  • UDLedge Science Citation Index
  • International Impact Factor Services
  • International Society for Research Activity (ISRA) Journal Impact Factor (JIF)
  • Scientific Journal Impact Factor (SJIF)
  • IFSIJ Measure of Journal Quality
  • International Scientific Indexing, UAE (ISI) (Under Process)
  • International Impact Factor Services (IIFS)
  • Web of Science Group (Under Process)
  • Directory of Research Journals Indexing
  • Scholar Article Journal Index (SAJI)
  • International Scientific Indexing ( ISI )
  • Academia
  • Scope Database
  • Research Publication Rating and Indexing
  • Doi-Digital Online Identifier
  • ISSN National Centre
  • Zenodo Indexing
  • International CODEN Service, USA

Abstract

AN OPEN LABEL SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFICACY OF HABBE BAWASEER ON BAWASEER KHOONI (BLEEDING PILES)

Dr. Shaikh Sana Kausar Gulam Mustafa*, Dr. Manzoor Ahmad, Dr. Akhtar Husain Charudhary, Dr. Saima Istayaque, Dr. Abid Sayyed

ABSTRACT

Bawaseer-e-Khooni (bleeding haemorrhoids) is a common anorectal disorder characterized mainly by per-rectal bleeding and may be associated with anal pain, pruritus, mass sensation, and constipation. In Unani medicine, Bawaseer is associated with humoral imbalance, particularly the accumulation of Saudavi Maddah and viscous blood, resulting in congestion and swelling of the haemorrhoidal vessels. Habbe Bawaseer is a classical Unani formulation traditionally used in the management of haemorrhoidal disorders. An open-label, single-arm clinical study was conducted in the Department of Ilmul Jarahat, Z.V.M. Unani Medical College & Hospital, Pune, from August 2024 to July 2026. Forty patients of either sex, aged 20–65 years, fulfilling the predefined inclusion criteria were enrolled. Patients received Habbe Bawaseer at a dose of 2 Habb twice daily with water for 28 days. Five assessment visits were conducted on Day 0, 7, 14, 21 and 28. Efficacy was assessed using subjective parameters including per-rectal bleeding, anal pain, anal pruritus, mass sensation and constipation, along with objective parameters such as proctoscopic examination and Hb %. Thirty patients completed the study and were included in the final statistical analysis. The treatment was assessed by comparing pre-treatment and post-treatment clinical findings and laboratory parameters. The study demonstrated improvement in the assessed symptoms and clinical findings among the patients who completed the treatment course. The formulation was generally well tolerated during the study period. Habbe Bawaseer showed beneficial effects in the management of uncomplicated Grade I and Grade II Bawaseer-e-Khooni. The findings support its potential usefulness as a Unani therapeutic option; however, larger controlled clinical studies are recommended to establish its efficacy and safety more conclusively.

[Full Text Article] [Download Certificate]